Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 26, 2024Blood AdvancesOpen Access

Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

RKReem KarmaliNorthwestern UniversityRMRushad MachhiNorthwestern UniversityNENarendranath EpperlaUniversity of Utah

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Karmali et al. (2024) studied this question.

synapsesocial.com/papers/68e7242fb6db64358769dc29https://doi.org/10.1182/bloodadvances.2023011996
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma2017 · 6,114 citations
  2. 2Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma2022 · 65 citations
  3. 3Understanding and Mitigating Health Inequities — Past, Current, and Future Directions2021 · 168 citations
  4. 4Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer2016 · 484 citations
  5. 5Race, rituximab, and relapse in TTP2022 · 42 citations